View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 19, 2017

Medtronic releases spinal cord stimulator for chronic pain in US

Medtronic has launched the Intellis platform with a small implantable spinal cord stimulator for the management of select types of chronic intractable pain in the US.

Medtronic has launched the Intellis platform with a small implantable spinal cord stimulator for the management of select types of chronic intractable pain in the US.

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

Following approval from the US Food and Drug Administration (FDA), the Intellis device was implanted in the first patient at the Duke University Medical Centre in North Carolina.

Intended to address the limitations with existing spinal cord stimulation (SCS) systems, the new device leverages the Evolve workflow to balance high-dose (HD) and low-dose (LD) therapy settings.

Medtronic Pain Therapies division senior vice-president and president Marshall Stanton said: “Drawing upon our 40-year legacy in SCS, the launch of the Intellis platform isn't just about a new device, but about combining cutting-edge hardware with optimal therapy through the Evolve workflow to enable personalised, long-term pain relief.

"The Intellis platform tracks and shares the information on daily activities, body positions and therapy usage to optimise treatment and improve communication."

“We considered the entire patient journey starting with the primary goal of optimal pain relief and access to important diagnostic tools, like MRI, to ease of use with simplified programming, faster recharge and a smaller implant.”

The Intellis platform tracks and shares the information on daily activities, body positions and therapy usage to optimise treatment and improve communication between the patient and physician.

It features the firm’s Overdrive battery technology that enables complete recharge in around one hour, SureScan MRI technology for MRI scanning anywhere on the body under select conditions, and AdaptiveStim technology to automatically adjust accurate dose delivery.

The device can be managed on the Samsung Galaxy Tab S2 tablet interface and allows physicians to monitor progress or make modifications to the therapy based on patient needs.


Image: Medtronic's Intellis spinal cord stimulation platform. Photo: courtesy of Medtronic plc.

Related Companies

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network